HRT FINANCIAL LP
10% owner
SaleAlert
- Shares
- 49,710
- Price
- $0.69
- Value
- $34,300
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•11 filings
ONCO
Onconetix, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$152,875
1 distinct insiders
12-month sales
$144,469
1 distinct insiders
Highlighted alerts
6
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get ONCO insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ONCO overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
14
Raw transactions
Everything returned by the filing
6
Voluntary view
P/S trades after deterministic checks
4
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 618
- Price
- $0.00
- Footnotes
- 3
Represents a restricted stock award originally granted to the Reporting Person on March 23, 2025 pursuant to the Issuer's 2022 Equity Incentive Plan, as amended ("2022 Plan" and the grant on such date, the "Original Award"). On August 15, 2025, the Original Award was modified to change the vesting terms, such that the award, which was to vest in full on August 31, 2025, was changed to vest in full on August 31, 2026, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Except as set forth herein, the Original Award remains unmodified. On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis. Represents a restricted stock award granted to the Reporting Person pursuant to the 2022 Plan. The award will vest in full on August 31, 2026 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
HRT FINANCIAL LP
10% owner
SaleAlert
- Shares
- 94,462
- Price
- $0.75
- Value
- $70,847
HRT FINANCIAL LP
10% owner
PurchaseAlert
- Shares
- 34,636
- Price
- $0.73
- Value
- $25,284
HRT FINANCIAL LP
10% owner
SaleAlert
- Shares
- 53,867
- Price
- $0.73
- Value
- $39,323
HRT FINANCIAL LP
10% owner
PurchaseAlert
- Shares
- 92,554
- Price
- $0.76
- Value
- $70,341
HRT FINANCIAL LP
10% owner
PurchaseAlert
- Shares
- 74,350
- Price
- $0.77
- Value
- $57,250
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | HRT FINANCIAL LP 10% owner | Sale | 49,710 | $0.69 | $34,300 | |
| Apr 20, 2026 | HRT FINANCIAL LP 10% owner | Sale | 94,462 | $0.75 | $70,847 | |
| Apr 17, 2026 | HRT FINANCIAL LP 10% owner | Purchase | 34,636 | $0.73 | $25,284 | |
| Apr 16, 2026 | HRT FINANCIAL LP 10% owner | Sale | 53,867 | $0.73 | $39,323 | |
| Apr 15, 2026 | HRT FINANCIAL LP 10% owner | Purchase | 92,554 | $0.76 | $70,341 | |
| Apr 14, 2026 | HRT FINANCIAL LP 10% owner | Purchase | 74,350 | $0.77 | $57,250 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.